Navigation Links
Vaginal reconstruction not needed for most inter-sex females, Hopkins study shows
Date:10/27/2007

Dispelling a common myth, researchers from the Johns Hopkins Childrens Center say vaginal reconstruction should be a matter of preference for most teens or adult women born with a type of inter-sex condition marked by the presence of both female and male genitals. The findings of the research are being presented at the American Academy of Pediatrics Conference Oct. 26 through Oct. 30 in San Francisco.

Women with complete androgen insensitivity are born with relatively shallow vaginas that may or may not require surgical repair and with undescended testes that do require removal.

Vaginal surgery, if needed or wanted, should be done after puberty, when physical development is complete and a girl or a woman is mature enough to make a decision, researchers say.

It is a common misconception in the general public and quite often among doctors that most girls born with this condition should have vaginal reconstruction in order to be sexually active, says lead investigator Todd Purves, M.D. Ph.D., a urologist at Hopkins Childrens. Our findings show that, on the contrary, most young women choose not to have the surgery, have vaginal depths that are within normal parameters and can lead active sexual lives.

In their study of 29 women born with the syndrome, researchers found that 38 percent chose to have vaginal surgery. Comparing those who had surgery with those who did not, researchers found that both groups had similar rates of sexual activity: Eighty percent of those who chose not to have surgery were sexually active, compared to 70 percent of those who had surgery.

As surgeons, we need to make sure that the parents of babies with this disorder understand that their daughter may not even need vaginal surgery, and if she does, it is a decision that should wait until after adolescence, Purves says.

Gender identity in women born with this condition is almost always female.


'/>"/>

Contact: Katerina Pesheva
epeshev1@jhmi.edu
410-926-6780
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1

Related biology news :

1. Vaginal gel may provide a new approach to HIV prevention
2. UCSF study will test new vaginal microbicide for herpes and HIV
3. Fat stem cells being studied as option for breast reconstruction
4. Tissue engineering for craniofacial reconstruction
5. A much-needed shot in the arm for HIV vaccine development
6. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
7. Clear rules needed to govern deep sea bioprospecting: UNU
8. Quick identification needed to save Floridas citrus industry from devastating disease
9. Womb needed for proper brain development
10. Molecular research suggest shift needed in how some drugs are created
11. Gene needed for butterfly transformation also key for insects like grasshoppers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
(Date:6/2/2016)... , June 2, 2016   The Weather Company ... announcing Watson Ads, an industry-first capability in which consumers will ... being able to ask questions via voice or text and ... Marketers have long sought an ... consumer, that can be personal, relevant and valuable; and can ...
(Date:6/1/2016)... Favorable Government Initiatives Coupled With ... Identification to Boost Global Biometrics System Market Through 2021  ... report, " Global Biometrics Market By Type, By ... 2011 - 2021", the global biometrics market is projected ... of growing security concerns across various end use sectors ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... announced the funding of a Sponsored Research Agreement ... circulating tumor cells (CTCs) from cancer patients.  The ... in CTC levels correlate with clinical outcomes in ... These data will then be employed to support ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology: